Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Isotechnika Pharma Inc IPHAF

Healthcare Biotechnology


GREY:IPHAF - Post by User

Isotechnika Pharma Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Post by blogon Feb 08, 2010 5:05pm
379 Views
Post# 16764067

Next stock driver

Next stock driverIt’s about time for Atrium to reveal trial results. This could be the next stock price driver. There are many potential stock price drivers, such as; Lux eye drops moving ahead; psoriasis deal; renal deal;  buy out; partnership; new experienced management team;  another autoimmune deal; etc.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities